864146-94-1 Usage
Molecular structure
1-(2-fluoro-4-nitro-phenyl)-4-methanesulfonyl-piperazine is a complex chemical compound consisting of a piperazine ring with a methanesulfonyl group attached to the 4 position and a 2-fluoro-4-nitro-phenyl group attached to the 1 position.
Fluorine atom
The 2-fluoro-4-nitro-phenyl group contains a fluorine atom, which is known for its high electronegativity and reactivity in various chemical reactions.
Nitro group
The 2-fluoro-4-nitro-phenyl group also contains a nitro group, which is a strong oxidizing agent and can participate in various chemical reactions, such as reduction and substitution.
Methanesulfonyl group
The methanesulfonyl group attached to the 4 position of the piperazine ring is a sulfonyl functional group that can act as a good leaving group in certain reactions.
Pharmaceutical industry potential
1-(2-fluoro-4-nitro-phenyl)-4-methanesulfonyl-piperazine has the potential for use in the pharmaceutical industry, possibly as a precursor or intermediate for the synthesis of drugs or other biologically active compounds.
Further research needed
The precise properties, uses, and potential hazards of 1-(2-fluoro-4-nitro-phenyl)-4-methanesulfonyl-piperazine would need to be further studied and evaluated to fully understand its applications and safety.
Check Digit Verification of cas no
The CAS Registry Mumber 864146-94-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,4,1,4 and 6 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 864146-94:
(8*8)+(7*6)+(6*4)+(5*1)+(4*4)+(3*6)+(2*9)+(1*4)=191
191 % 10 = 1
So 864146-94-1 is a valid CAS Registry Number.
864146-94-1Relevant articles and documents
IMIDAZOQUINOLINES AS LIPID KINASE INHIBITORS
-
Page/Page column 64, (2008/06/13)
The invention relates to novel organic compounds of formula (I) processes for the preparation thereof, the application thereof in a process for the treatment of the human or animal body, the use thereof - alone or in combination with one or more other pharmaceutically active compounds - for the treatment of an inflammatory or obstructive airway disease, such as asthma, disorders commonly occurring in connection with transplantation, or a proliferative disease, such as a tumor disease.
NOVEL TRIAZOLE COMPOUNDS AS ANTIBACTERIAL AGENTS AND THEIR PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
-
Page/Page column 60, (2010/02/13)
The present invention relates to novel triazole compounds of formula (I), where all symbols are as defined in the detailed description; their pharmaceutically acceptable salts their stereosiomers thereof, their prodrugs, their rotamers, their pharmaceutical compositions containing them. The present invention also relates to a process for the preparation of the above said novel compounds.